The chemical class designated as IRG1 Activators encompasses a diverse group of compounds that share the common function of inducing the expression of the immune-responsive gene 1 (IRG1) protein. These molecules are of particular interest due to their ability to engage with and modulate the immune system's metabolic pathways. IRG1 activators can be found in a variety of sources, including natural substances found in plants, synthetic compounds designed to mimic pathogenic components, and even metabolic byproducts. The primary unifying characteristic of these activators is their capacity to stimulate the cellular mechanisms that lead to the upregulation of IRG1, a key player in the immune response to environmental challenges. While their structures and origins are varied, the outcome of their interaction with immune cells converges on the enhancement of itaconate production, a metabolite significant for its role in immune cell function.
The mechanisms through which IRG1 activators exert their influence are multifaceted and interconnected with the core signaling pathways of immune cells. For instance, some activators function by mimicking the presence of pathogens, engaging toll-like receptors (TLRs) and triggering a defensive cellular response that includes the upregulation of IRG1. Others may interact with cellular pathways that control the transcriptional machinery, leading to increased expression of the IRG1 gene. The actions of these compounds are often associated with alterations in the cellular redox state, modulation of inflammatory responses, and the reprogramming of cellular metabolism. Despite the different molecular pathways they affect, IRG1 activators collectively contribute to the dynamic regulation of immune responses, illustrating the profound impact that small molecules can have on the complex network of immune regulation. Through their interaction with cellular processes, these activators provide valuable insights into the intricate balance between metabolic and immune system dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
Induces macrophage activation and subsequent cytokine production, which can lead to the upregulation of IRG1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Has immunomodulatory effects and can activate Nrf2 signaling, potentially affecting IRG1 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates NF-κB pathway, which is implicated in the expression of a wide range of immune-responsive genes, possibly including IRG1. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $286.00 $806.00 $1510.00 | 1 | |
Affects macrophage metabolism and has been shown to have anti-inflammatory effects, which could indirectly upregulate IRG1. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $154.00 $276.00 $506.00 $1154.00 $19743.00 $32136.00 $69366.00 | 1 | |
TLR7 agonist that can activate immune responses, possibly upregulating IRG1 as part of that response. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
TLR7/8 agonist that activates innate immune responses, potentially increasing IRG1 expression. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
TLR1/2 agonist that can trigger immune cell activation, potentially leading to increased IRG1 expression. | ||||||